Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 6, 2026 · Filed Nov 6, 2026
An Annovis Bio director paid $5M out of pocket for Annovis Bio shares. It was the first purchase in 6 months. Shares held went up 149% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$5,000,000
Shares × reported transaction price
$1M+
+148.6%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 6 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 18 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
2 days after results of Nov 4, 2026, 7 days before results of Nov 13, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $0.8449 on Nov 6, 2026, 26% above its 52-week low and 83% below its high, after a 36% drop over the previous 30 trading days
52-week range $0.6689 (Nov 5, 2026) to $5.10 (Nov 28, 2025), 4% of the way up, from 251 adjusted closes. 30 trading days earlier: $1.31 on Sep 25, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The largest open-market purchase by any ANVS insider in filings since 2020. Traded 7 days before ANVS reported its results (Nov 13, 2026). Michael B Hoffman's largest purchase of ANVS in their filings since 2020
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider filing
Traded Nov 6 · filed the same day
Not classified as an open-market trade.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Michael B Hoffman, Director's past purchases, 90 days after disclosure: 7 buys, median −32.6 pts vs S&P 500, beat it 1 of 7 times. Past results, not a forecast.
